Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05292365 · ClinicalTrials.gov registry record · NA

Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT05292365 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05292365, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study will pilot test a just-in-time (JIT) adaptive intervention to reduce severe respiratory illness, for children with severe cerebral palsy (CP). The intervention program, called RE-PACT, delivers timely, customized action planning and health coaching when mobile text messaging with families predicts hospitalization risk is elevated. A total of n=90 caregivers of children with severe CP will be enrolled from the University of Wisconsin-Madison (UW) and the University of California, Los Angeles (UCLA) and can expect to be on study for up to 6 months.

Interventions

  • BEHAVIORAL RE-PACT Intervention

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-04-27
Est. Completion 2024-02-27
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05292365

The ClinicalTrials.gov registry entry for NCT05292365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which RE-PACT Intervention is the first listed.

NCT05292365 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05292365 about?

NCT05292365 is a clinical study titled "Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP". This study will pilot test a just-in-time (JIT) adaptive intervention to reduce severe respiratory illness, for children with severe cerebral palsy (CP). The intervention program, called RE-PACT, delivers timely, customized action planning and health coaching when mobile text messaging with families...

What is the current status of trial NCT05292365?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-04-27. Estimated completion is 2024-02-27.

What interventions are being tested in trial NCT05292365?

The interventions under investigation include: RE-PACT Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05292365?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.